Genomic Vision Société Anonyme announce the successful evaluation of its DNA combing technology by the US National Institute of Standards and Technology (‘NIST'). The evaluation has confirmed the high accuracy of the technology for quantitative analysis of genomic events at or greater than 10 kilobases. Within this Consortium, Genomic Vision's Quality Control Assay (‘QCA') was employed to identify, characterize, and quantify mid to large-size genomic variants occurring in a specific human population.

The results were compiled by NIST and compared to other datasets obtained within the Consortium. NIST determined that Genomic Vision's technology produced high quality results. The global results issued from the Consortium will be disclosed by NIST in spring 2023.

Genomic Vision's technology allows for highly sensitive and digitally quantifiable analysis of structural and functional genome modifications and provides a quality control tool for the safety and optimization of engineered cells. The data output enables an unbiased assessment of genetic events through direct visualization of modifications on single DNA molecules.